Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluates the combination of cirmtuzumab and ibrutinib in patients with B-cell lymphoid malignancies, includi…
-
FDA approval · 2025-01-31FDA Approved: LENALIDOMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic lenalidomide (LENALIDOMIDE) under an Original Application (ANDA 216213).
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. [Phase 1, Phase 2]
A Phase 1/2 open-label trial evaluating the safety and efficacy of concomitant administration of anti-CD19 CAR T-cell therapy and Lenalidomi…
-
CLINICAL_TRIALS approval · 2024-12-18Clinical Trial Update: Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
The document notes that pirtobrutinib is approved for marketing in relation to an expanded access program for multiple B-cell cancers, cover…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 1]
Phase 1 trial evaluating SD-101 (TLR9 agonist) and BMS-986178 (anti-OX40 antibody) with radiation therapy for low-grade B-cell non-Hodgkin l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies [Phase 1, Phase 2]
Update on the completed Phase 1/2 study of ZX-101A assessing activity, safety, and tolerability in relapsed/refractory hematological maligna…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating zanubrutinib in combination with obinutuzumab in untreated chronic lymphocytic leukemia or small lymphoc…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL [Phase 2]
Phase 2 study evaluating idelalisib plus ofatumumab in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma; the…
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Cardiotoxicities in Patients Receiving BTKi
A clinical trial evaluating cardiotoxicities in patients receiving Bruton's tyrosine kinase inhibitors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating acalabrutinib in combination with high-frequency, low-dose subcutaneous rituximab in previously untreated chronic l…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial update showing results for ofatumumab in high-risk chronic lymphocytic leukemia and small lymphocytic lymphoma, with trial res…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating Zydelig (idelalisib) as maintenance therapy after autologous stem cell transplantation in B-cell non-Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]
Open-label extension Phase 3 study in patients aged 65 and older with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; results po…
-
FDA approval · 2024-09-11FDA Approved: LENALIDOMIDE — Original Application (Novugen Pharma (USA) LLC)
FDA approved the original application for lenalidomide from Novugen Pharma (USA) LLC, enabling a generic version of the cancer drug lenalido…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating the effect of Vitamin D on progression-free survival in indolent non-Hodgkin lymphoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas [Phase 1, Phase 2]
First-in-human study of GEN3009 in relapsed or refractory B-cell non-Hodgkin lymphomas was terminated, with results posted thereafter.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: A Study of FCN-338 in Patients With Chronic CLL/SLL [Phase 1]
FCN-338 is being evaluated in a Phase 1 trial for chronic lymphocytic leukemia and small lymphocytic lymphoma, with the study currently acti…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 1]
Phase 1 trial evaluating a triple combination of zanubrutinib, obinutuzumab, and lenalidomide in newly diagnosed chronic lymphocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating intermittent dosing of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A terminated clinical trial update investigates immune responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia or sma…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 study assessing TG-1801 alone or with ublituximab in patients with CLL, SLL, and other B-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-99282 in combination with obinutuzumab in patients with relapsed or refractory chronic l…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL [Phase 1, Phase 2]
Mustang Bio's MB-106 study in relapsed or refractory B-cell lymphomas and chronic lymphocytic leukemia has been terminated, covering Phase 1…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
A long-term follow-up update on patients previously treated with Mustang Bio's CAR-T cell investigational product; the trial has been termin…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Current Status of BTKi Treatment for CLL/SLL in China
An update on a Bruton tyrosine kinase inhibitor (BTKi) trial for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in China,…